Qaytona is free while it's in beta — Get started

Ingredients

DMAE

Dimethylaminoethanol · Deanol

Snapshot

IndicationsContraindications
  • Attention-deficit/hyperactivity disorder1, 2
  • Skin firmness (topical)3
  • Behavioral symptoms in senile dementia4
  • Lucid dream induction5
  • Seizure disorder6
  • Bipolar disorder6
  • Pregnancy or lactation6

Dimethylaminoethanol (DMAE), also called deanol, is a choline-related compound assumed to raise brain acetylcholine. It is taken for attention and focus, including in attention-deficit/hyperactivity disorder (ADHD), where it probably has a small effect. It is also used for behavior in older adults with dementia, for skin firmness in topical products, and for lucid dream induction.

Systematic reviews found deanol no more effective than placebo for tardive dyskinesia, with more adverse events, including gastric and sedative effects7. A double-blind Alzheimer's disease trial found no significant benefit, and several participants withdrew for drowsiness and increased confusion8. A 2007 split-face trial of a topical product combining herbal extracts and DMAE found improved skin firmness3. In a 2026 cell-model study, DMAE, unlike other pre-workout alkylamines, did not inhibit human dopamine, noradrenaline, or serotonin transporters; no human trial has examined this. Products listing DMAE number over one thousand, mostly capsules and tablets; see Form comparison.

The psychiatric cautions rest on a 1979 report of depression or hypomania in patients taking high-dose deanol, most with prior affective symptoms9. Product labels in the United States list seizure disorder and bipolar illness as conditions in which DMAE is not to be taken6.

Last updated October 16, 2026. Read how we make monographs.

In the full monograph

41 sources, 31 studies

  • When to useThe situations practitioners use it for, each with the reason and the study behind it.
  • SafetyWho should avoid it, who needs extra care, and the side effects reported in studies.
  • InteractionsThe medicines and supplements it interacts with, the effect of each, and what labeling says to watch.
  • Protocol notesThe doses used in studies, how and when they were taken, and how the forms on the market compare.
  • How it worksWhat it is and how it works in the body, in plain terms.
  • Published studiesThe studies behind each use, popular claims checked against them, and trials still under way.
  • Word of mouthWhat patients and practitioners report online, kept separate from the clinical evidence.
  • Clinical perspectiveA closing read of where the evidence is solid, where it is thin, and what has not been studied.

Sources

  1. 1Deanol and methylphenidate in minimal brain dysfunction.pubmed.ncbi.nlm.nih.govLewis, Young · Clinical pharmacology and therapeutics · 1975 · Pubmed
  2. 2Dietary and nutritional treatments for attention-deficit/hyperactivity disorder: current research support and recommendations for practitioners.pubmed.ncbi.nlm.nih.govHurt, Arnold, Lofthouse · Current psychiatry reports · 2011 · Pubmed
  3. 3Randomised, placebo-controlled, double-blind, split-face study on the clinical efficacy of Tricutan on skin firmness.pubmed.ncbi.nlm.nih.govSommerfeld · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2007 · Pubmed
  4. 4Senile dementia: treatment with deanol.pubmed.ncbi.nlm.nih.govFerris, Sathananthan, Gershon et al. · Journal of the American Geriatrics Society · 1977 · Pubmed
  5. 5Use of DMAE (2-dimethylaminoethanol) in the induction of lucid dreams.pubmed.ncbi.nlm.nih.govSergio · Medical hypotheses · 1988 · Pubmed
  6. 6US product labelsdsld.od.nih.govWarnings printed on US dietary supplement labels with this ingredient, from the NIH Office of Dietary Supplements' Dietary Supplement Label Database (DSLD). Manufacturers' precautions, not evidence of harm
  7. 7The treatment of tardive dyskinesia--a systematic review and meta-analysis.pubmed.ncbi.nlm.nih.govSoares, McGrath · Schizophrenia research · 1999 · Pubmed
  8. 8Double-blind trial of 2-dimethylaminoethanol in Alzheimer's disease.pubmed.ncbi.nlm.nih.govFisman, Mersky, Helmes · The American journal of psychiatry · 1981 · Pubmed
  9. 9Mood alterations during deanol therapy.pubmed.ncbi.nlm.nih.govCasey · Psychopharmacology · 1979 · Pubmed